使scFv,

Kamran Heidarnejad1, Seyed Nooreddin Faraji2, Shirin Mahfoozi1

  • 1Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.

Human immunology
|August 30, 2024
PubMed
概括

本综述探讨了针对乳腺癌的单链片段变量 (scFv) 抗体免疫疗法,这是女性癌症死亡的主要原因. 它强调了共同的目标和方法,提供了对这种有前途的治疗策略的见解.